Mouwasat Medical Services Company Stock

Equities

4002

SA12C051UH11

Healthcare Facilities & Services

Market Closed - Saudi Arabian S.E. 08:20:05 2024-05-30 am EDT 5-day change 1st Jan Change
107 SAR -0.56% Intraday chart for Mouwasat Medical Services Company -8.70% -4.29%
Sales 2024 * 3.05B 813M Sales 2025 * 3.58B 955M Capitalization 21.4B 5.71B
Net income 2024 * 753M 201M Net income 2025 * 879M 235M EV / Sales 2024 * 7.19 x
Net Debt 2024 * 521M 139M Net Debt 2025 * 352M 93.82M EV / Sales 2025 * 6.08 x
P/E ratio 2024 *
27.1 x
P/E ratio 2025 *
23.5 x
Employees 2,389
Yield 2024 *
1.81%
Yield 2025 *
2.56%
Free-Float 47.5%
More Fundamentals * Assessed data
Dynamic Chart
Mouwasat Medical Services Company Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Tadawul All Share Index Down; Saudi's Biggest IPO of the Year Prices MT
Mouwasat Medical Services Sees Profit, Revenue Growth in Q1 MT
Mouwasat Medical Services Company Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Saudi Arabia's Mouwasat Medical Services Reports Improved FY23 Profit, Revenue MT
Mouwasat Medical Services Company Recommends Distribution of Cash Dividend for the Fiscal Year Ended December 31, 2023 CI
Mouwasat Medical Services Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Mouwasat Medical Services Company Reports Earnings Results for the Second Quarter Ended June 30, 2023 CI
Mouwasat Medical Services Company Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Mouwasat Medical Services Company Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Mouwasat Medical Services Company Announces Executive Appointments CI
Mouwasat Medical Services Company Approves Appointment of Dr. Mohammed Hamad Alkathiri as Member of the Board of Directors and Audit Committee CI
Mouwasat Medical Services Co. Recommends the Distribution of Cash Dividend for Year 2022 CI
Mouwasat Medical Services Company Reports Earnings Results for the Third Quarter Ended September 30, 2022 CI
Mouwasat Medical Services Company completed the acquisition of Jeddah Doctors Company for SAR 102 million. CI
More news
1 day-0.56%
1 week-8.70%
1 month-20.39%
3 months-13.29%
6 months-4.97%
Current year-4.29%
More quotes
1 week
104.60
Extreme 104.6
117.00
1 month
104.60
Extreme 104.6
138.40
Current year
104.60
Extreme 104.6
144.00
1 year
92.50
Extreme 92.5
144.00
3 years
79.40
Extreme 79.4
144.00
5 years
34.15
Extreme 34.15
144.00
10 years
23.50
Extreme 23.5
144.00
More quotes
Managers TitleAgeSince
Chief Executive Officer - 06-01-23
Director of Finance/CFO - 17-01-03
Director/Board Member - 20-01-03
Members of the board TitleAgeSince
Chairman - 20-01-03
Chief Executive Officer - 06-01-23
Director/Board Member 56 20-01-03
More insiders
Date Price Change Volume
24-05-30 107 -0.56% 765,952
24-05-29 107.6 -1.28% 707,142
24-05-28 109 -2.50% 622,054
24-05-27 111.8 -2.78% 419,662
24-05-26 115 -1.88% 122,507

Delayed Quote Saudi Arabian S.E., May 30, 2024 at 08:20 am EDT

More quotes
Mouwasat Medical Services Company is a Saudi Arabia-based company, which is engaged, through its multiple branches, in the acquisition, management, operation and maintenance of hospitals, medical centers, drug stores, pharmacies and wholesale of medical equipment and drugs. The Company operates in two segments: medical services segment, which includes Inpatient and outpatient services and pharmaceuticals segments. The Company also operates specialize centers, which include Long term care, rehabilitation center, stroke unit, cardiology center, nuclear medicine, fertility, skin care and badana clinic, among others. The Company operates approximately 9 branches and The Company’s subsidiaries includes Eastern Medical Services Company Limited and Jeddah Doctors Company.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
107 SAR
Average target price
127.5 SAR
Spread / Average Target
+19.14%
Consensus